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Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-associated infection,
but there is growing awareness of the emergence of multidrug-resistant lineages in community settings around the
world. One such lineage is ST772-MRSA-V, which has disseminated globally and is increasingly prevalent in India.
Here, we present the complete genome sequence of DAR4145, a strain of the ST772-MRSA-V lineage from India,
and investigate its genomic characteristics in regards to antibiotic resistance and virulence factors.
Results: Sequencing using single-molecule real-time technology resulted in the assembly of a single continuous
chromosomal sequence, which was error-corrected, annotated and compared to nine draft genome assemblies of
ST772-MRSA-V from Australia, Malaysia and India. We discovered numerous and redundant resistance genes associated
with mobile genetic elements (MGEs) and known core genome mutations that explain the highly antibiotic resistant
phenotype of DAR4145. Staphylococcal toxins and superantigens, including the leukotoxin Panton-Valentinin
Leukocidin, were predominantly associated with genomic islands and the phage φ-IND772PVL. Some of these
mobile resistance and virulence factors were variably present in other strains of the ST772-MRSA-V lineage.
Conclusions: The genomic characteristics presented here emphasize the contribution of MGEs to the emergence of
multidrug-resistant and highly virulent strains of community-associated MRSA. Antibiotic resistance was further
augmented by chromosomal mutations and redundancy of resistance genes. The complete genome of DAR4145
provides a valuable resource for future investigations into the global dissemination and phylogeography of ST772-MRSA-V.
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Staphylococcus aureus is one of the leading causes of
hospital-associated infections worldwide, with clinical
manifestations including skin and soft-tissue infections,
sepsis, pneumonia and toxic shock syndrome. A large
proportion of these infections can be attributed to glo-
bally disseminated, methicillin-resistant clones associated
with healthcare settings (HA-MRSA), often arising in
individuals with predisposing risk factors [1]. In the past
two decades, community-associated methicillin-resistant S.
aureus (CA-MRSA) clones distinct from HA-MRSA clones* Correspondence: steven.tong@menzies.edu.au
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unless otherwise stated.have emerged to cause infections in otherwise healthy
individuals and are often characterised by enhanced
virulence and transmissibility [2]. Some of these clones have
become a major cause of nosocomial infections, obscuring
the distinction between CA-MRSA and HA-MRSA [3-5].
Although most research has so far originated from
industrialised countries such as the United Kingdom and
United States [2], there is an increasing awareness of
the emergence of CA-MRSA clones in non- and newly-
industrialised nations in Africa, Asia and the Indian sub-
continent [6-11]. Some of these clones have now become
globally disseminated [2,10].
Sequence type 772 (ST772) was originally isolated
from India and Bangladesh, where it has becomeThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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invading healthcare environments and displacing previ-
ously successful nosocomial MRSA [7,15]. It has subse-
quently been identified in England, France, Germany,
Ireland, Italy, Norway, Abu Dhabi, Saudi-Arabia, Malaysia,
Australia and New Zealand [8], often in patients with family
background or travel histories to India or Bangladesh [15-
18]. In the past few years, several draft genomes have been
assembled, revealing the genomic composition of ST772-
MRSA-V [19-23]. This lineage is closely related to clonal
complex CC1 and harbours the relatively small and mobile
staphylococcal cassette chromosome SCCmec type V [22].
The draft genomes accommodate a novel prophage Φ-
IND772PVL, carrying the enterotoxin gene sea and an
operon encoding Panton-Valentine Leukocidin (PVL),
lukS/F-PV [21]. This potent combination of toxins on
the same prophage has so far not been reported in other
strains of S. aureus [21]. A heavily truncated hlb-converting
phage is also present, which carries only scn (staphylococcal
complement inhibitor) as part of the immune evasion cluster
[21]. In addition, a variety of enterotoxins and superantigens
have been detected in ST772-MRSA-V, including the variable
presence of sec and sel, as well as the enterotoxin gene cluster
egc [8,15,20]. Finally, several genes encoding antibiotic resist-
ance determinants (e.g., against beta-lactams, aminoglyco-
sides, fluoroquinolones, tetracyclines) and non-synonymous
mutations in resistance-associated genes have been discov-
ered, which correspond to previously identified multidrug
resistant phenotypes of ST772-MRSA-V [7,15,20,24].
Despite these advances, the genomic location and
context of resistance and virulence factors, which are
frequently associated with mobile genetic elements
(MGEs) [1,25], has not yet been unambiguously deter-
mined in ST772-MRSA-V [8,20]. Published draft ge-
nomes of ST772-MRSA-V have employed short-read
sequencing technologies (i.e., Illumina), resulting in rela-
tively fragmented assemblies (43–78 contigs, Table 1)
and annotations and may lack important positional
information of elements associated with resistance or
virulence (e.g., resistance genes in [20]). Recently, third-
generation sequencing technologies have allowed for the
closure of complex genomic regions and the recovery of
contiguous genome sequences [26,27], including for
S. aureus [28-30].
In this study, we present the complete genome sequence
of DAR4145, a multidrug resistant strain of ST772-MRSA-
V from Mumbai, India [31]. Pacific Bioscience (PacBio)
single-molecule real-time (SMRT) sequencing resulted in
a single contig containing the complete chromosome of
DAR4145, which was error checked and corrected with
Illumina reads. Annotation and comparison to nine other
isolates from Australia, Malaysia and India highlighted an
association of resistance and virulence determinants with
MGEs. Additional resistance-associated mutations and generedundancy explain the multidrug-resistant phenotype of
DAR4145. The closed genome sequence fully defines the
genomic composition of DAR4145 and provides a valuable
reference genome for future investigations into the genomic
epidemiology and phylogeography of ST772-MRSA-V.
Results and discussion
SMRT sequencing and subsequent assembly generated
a single continuous sequence containing the complete
chromosome of DAR4145 (Figure 1). A second shorter
sequence was identical to the plasmid pKH-18, carrying
cadmium resistance gene cadD and its regulator cadX
[GenBank: EU333812.1]. The length of the completed
chromosome was 2,860,508 base pairs (bp) with a G + C
content of 32.85%. 2,642 protein coding regions, as well
as 18 rRNAs, 61 tRNAs, 25 ncRNAs (including RNAIII
and sprD) and 35 transposases associated with insertion
sequence elements and transposons (including partial
and putative sequences) were identified and annotated.
Notably, gaps in the draft genome assemblies of other
strains of ST772-MRSA-V (Figure 1) frequently occurred in
the vicinity of transposases, suggesting that some of the
short read assemblies were unable to bridge gaps associated
with repetitive genomic elements. This clearly emphasizes
the potential for obtaining fully defined de novo assemblies
using third-generation sequencing technologies, which
are able to resolve both local and global repeats [32] and
avoid the introduction of reference bias. In silico multi-
locus sequencing typing confirmed ST772, with a single al-
lele divergence from ST1 (pta-22). Although a single locus
variant of ST1 (and thus part of clonal complex 1), the agr
locus of DAR4145 is part of agr group II rather than group
III. A close relationship of the core genome is evident
for all available genomes of ST772-MRSA-V. Excluding
MGEs, the pairwise core genome SNP differences between
DAR4145 and other ST772-MRSA-V genomes ranged from
52 to 254 SNPs (Table 1). DAR4145 harbours the staphylo-
coccal cassette chromosome SCCmec type V containing
the cassette recombinase ccrC2; the composition and ar-
rangement are nearly identical to the previously identified
SCCmec in strain 118 [22], with the exception of an
additional mobile element inserted immediately upstream
of the terminal direct repeat DR2. The element carried
the bifunctional aminoglycoside modifying gene aacA-
aphD and was flanked by transposases of IS256. Its com-
position identified the element as transposon Tn4001 [33]
[GenBank: AB682805.1] and it was present at the same
location in all available genomes of ST772-MRSA-V, ex-
cept strain 118 (Figure 1).
Resistance to multiple antibiotics mediated by mobile
genetic elements
We found several additional resistance-associated genes,
most of which were located on MGEs and correlated
Table 1 Draft genomes of ST772-MRSA-V used for comparison with DAR4145
Strain Origin Year of isolation Core genome
SNPs vs. DAR4145
Number of contigs Publication Genbank accession
07-01748 Western Australia 2007 72 70 Monecke et al. [20] AZBT00000000
KT/Y21 Terrenganu, Malaysia 2009 73 70 Suhaili et al. [23] AOCQ00000000
118 Bangalore, India 2008 70 78 Prabhakara et al. [21] AJGE00000000
120 Bangalore, India 2009 52 56 Prabhakara et al. [21] ALWE00000000
333 Madurai, India 2010 78 54 Prabhakara et al. [21] ALWF00000000
VH60 Bangalore, India 2007 65 44 Prabhakara et al. [21] ALWG00000000
3989 Hyderabad, India 2007 79 43 Prabhakara et al. [21] ALWH00000000
LVP2 Bhubaneshwar, India 2010 119 73 Balakuntla et al. [22] AOFV00000000
3957 Hyderabad, India 2007 254 43 Balakuntla et al. [22] AOFU00000000
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One core genome copy of the dihydrofolate reductase
gene dfrA and two copies of dfrG were identified, which
have been linked to high-level trimethoprim resistance
in S. aureus [34]. The first copy of dfrG was found in the
context of several phage genes and within the boundary
of the terminal attachment site (attR) of a putatitve
SaPI, partially identical with the pathogenicity island
SaPITokyo12381 (BLASTn 99% identity, 70% coverage)
[GenBank: AB860418.1]. The island also contained the
enterotoxin genes sec and sel, placed in a similar context
and position as vSa3 Type II, a pathogenicity island of
strain MW2 [35]. Monecke et al. [8] noted the frequent
but variable presence of sec and sel in ST772-MRSA-V,
which was supported in this study by the absence of the
putative SaPI in strain 3989 (Figure 1). The second copy
of dfrG was found in the chromosome at 2,474,700 bp.
Both sequences, with two adjacent coding regions for
hypothetical proteins, were identical to genomic regions in
ST239 strain TW20 from the UK [36], the trimethoprim-
resistant S. pyogenes strain A1085 from India [37] and part
of the transposon Tn6198 from Listeria monocytogenes
[38] [GenBank: FN433596.1, GenBank: JX498941.1,
GenBank: JX120102.1]. Analysis with ResFinder [39] con-
firmed the presence of the two dfrG copies in DAR4145,
but only identified the SaPI-associated copy in the draft
genomes of 07–17048, 118, 3957 and KT/Y21 and the
core-associated copy in isolates 120, 333, 3989, LVP2,
VH60. The presence of dfrG was also confirmed by map-
ping paired-end short reads against our resistome database
and corresponded to a high-level trimethoprim/sulfameth-
oxazole (TMP-SXT) resistance phenotype of DAR4145
(MIC ≥ 320 μg/L) (Table 2). The dfrG gene was previously
thought to be rare in S. aureus colonising humans, but has
recently been found to be widespread in sub-Saharan
Africa [34].
Similarly, two copies of the beta-lactam resistance operon
(blaZ, blaI, blaR) were identified in DAR4145. The firstcopy was part of a partial integrated plasmid highly similar
in composition to the plasmid p18810-03 (BLASTn 99%
identity, 85% coverage) [GenBank: CP002141.1] found in
CA-MRSA strain 18810 of USA300 [40] and nearly identi-
cal with the integrated plasmid in strain 11819–97 of
CA-MRSA ST80-IV (BLASTn 99% identity, 99% coverage)
[GenBank: CP003194.1] [28]. The integrated plasmid
encoded a resistance cluster composed of aphA-III, sat4
and a partial aadE (aminoglycoside resistance), as well
as mphC and msrA (macrolide resistance), thus resol-
ving the genomic context of these genes previously
noted by Monecke et al. [20]. Draft genomes of strains
07–17048 and 120 respectively lacked or carried a trun-
cated, plasmid-associated blaZ, whereas the integrated
plasmid was entirely absent in strains 333 and 3957
(Figure 1, Table 2). The second copy of the beta-lactam
resistance operon was located immediately downstream of
three transposases related to Tn554 and was present in all
isolates of ST772-MRSA-V. The Tn554-like transposon
[41] was previously found with nearly identical sequence
composition in H-EMRSA-15 [CP007659.1] and HO 5096
0412 [GenBank: HE681097.1] of ST22 [41,42].
Resistance to multiple antibiotics mediated by core
chromosome genes and mutations
Three additional, chromosomal resistance genes identified
in DAR4145 were the transporter genes norA and norB,
whose altered expression is associated with quinolone
resistance [43,44] and the efflux pump tet(38), which
can confer resistance to tetracyclines when upregulated
[43,45,46]. The presence of tet(38) alone did not result in
phenotypic resistance for DAR4145 (Table 2). Notably,
tet(38) also facilitates the efflux of antibacterial fatty acids,
which promotes survival in an abscess environment and
colonisation of skin surfaces [46].
Furthermore, the chromosomal genes grlA/grlB and
gyrA/gyrB harbour common non-synonymous mutations
associated with increased resistance against quinolones
Figure 1 Comparison of draft genomes of nine strains of ST772-MRSA-V to the complete reference genome of strain DAR4145. The outer ring
describes the location of selected genes associated with antibiotic resistance (blue), resistance mutations (dark blue) and selected staphylococcal
toxins and superantigens (red) in DAR4145. The second ring denotes mobile genetic elements, including pathogenicity islands, phages and the
integrated resistance plasmid, as well as the staphylocccal cassete chromosome SSCmec-V-C2 (purple). The third ring designates the location of
transposases (orange) as determined by the final annotation of DAR4145. The subsequent rings and colours in the legend represent the strains
used for comparison with DAR4145.The innermost rings shows the GC content (black) and GC skew (green -, purple +). Note that redundant
genes in the reference genome (dfrG, blaZ) appear as multiple copies in the comparison genomes, even if they only exist as a single copy
(due to comparison based on BLAST).
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ST772-MRSA-V, one in grlA (S80Y, S80F in isolates
3957 and LVP2) and another in gyrA (S84L, in all ex-
cept isolate 118). These correspond to ciprofloxacin-
resistance associated mutations previously found in
ST772-MRSA-V and other STs from India [24]. We
also detected non-synonymous mutations in the genes
dfrA (V134I), ileS-1 (D621H) and mprF (L335S) that
were present in all examined strains of ST772-MRSA-V. These were located in the vicinity of mutations
that have previously been linked with resistance to
trimethoprim [50], mupirocin [51] and daptomycin
[34] in S. aureus, respectively.
Phage and virulence determinants
In addition to the antibiotic resistance factors and the
putative SaPI, DAR4145 harbours the genomic islands
vSaα, vSaβ and vSaγ. These were present in all investigated
Table 2 Selected phenotypic and genomic antibiotic resistance profiles in strains of ST772-MRSA-V
Antibiotic Phenotype (MIC μg/L) Resistance Genes and Mutations in ST772-MRSA-V
DAR4145 DAR4145 07-17048 KT/Y21 118 120 333 3957 3989 LVP2 VH60
Oxacillin R (≥4) mecA (M) + + + + + + + + + +
blaZ (M) + + + + + + + + + +
blaZ (P) + - + + +/− - - + + +
Gentamicin R (≥16) aacA-aphD (M) + + + - + + + + + +
aphA-III, sat4, aadE(p) (P) + + + +/− + - - + + +
Trimethoprim/Sulfamethoxazole R (≥320) dfrA (C) + + + + + + + + + +
dfrG (C) + - - - + + - + + +
dfrG (M) + + + + - - + - - -
Ciprofloxacin Levofloxacin Moxifloxacin R (4) R (4) I (1) norA/norB (C) + + + + + + + + + +
grlA (S80T/F) + + + + + + + + + +
gyrA (S84L) + + + + + + + + + +
Tetracyline S (≤1) tet(38) (C) + + + + + + + + + +
Erythromicin Clindamycin I (1) S ( ≤0.25) msrA-mphC (P) + + + + + - - + + +
(R = Resistant, I = Intermediate, S = Susceptible,C = Chromosomal, M = Mobile Genetic Element, P = Integrated Resistance Plasmid, + = present, − = absent, p = partial, +/− = partial or truncated).
Steinig
et
al.BM
C
G
enom
ics
 (2015) 16:388 
Page
5
of
10
Steinig et al. BMC Genomics  (2015) 16:388 Page 6 of 10genomes of ST772-MRSA-V (Figure 1) and encoded sev-
eral superantigen-like proteins and toxin determinants,
including the enterotoxin gene cluster (egc) on vSaβ as
well as α-haemolysin (hla) and exfoliative toxin A (eta) on
vSaγ. In addition, vSaα harbors aadK, encoding aminogly-
coside 6-adenylyltransferase, which is associated with low-
level streptomycin resistance in Bacillus subtilis [52]. The
recently described prophage Φ-IND772PVL, containing
the staphylococcal enterotoxin A (sea) and the PVL-
operon (lukF-PV, lukS-PV), was also found in all isolates,
confirming its widespread presence in ST772-MRSA-V
from India [21]. DAR4145 harboured the heavily trun-
cated hlb-converting prophage encoding the staphylococ-
cal complement inhibitor (scn) [20,21], immediately
followed by the hlg-related leukocidin genes lukF and lukS
[53]. We also found a second putative enterotoxin
gene with high similarity to sea within the chromosome
at 1,746,983 bp (BLASTn, 98% identity, 98% coverage
in CA-MRSA ST80-IV strain 11819–97) [GenBank
CP003194.1]. Additionally, DAR4145 contained one
previously undetected prophage region at 637,316 bp.
This prophage did not harbour known resistance or
virulence genes and the central region was present only in
DAR4145, 3957 and LVP2 (Figure 1). The entire region
was similar to φMu50B of strain Mu50 (BLASTn, 95%
identity, 83% of total coverage) [GenBank: BA000017.4],
with the core region showing highest similarity to φNM1
and φNM2 (BLASTn, 96% identity, 51-54% of total cover-
age) [GenBank: DQ530359.1 and DQ530360.1].
Finally, a putative and a truncated transposase for
IS1272 were found in the vicinity (−477 bp) of the global
transcriptional regulator of virulence rot (repressor of
toxins). Benson et al. [54] demonstrated that insertion
of IS257 elements into the promoter region of rot
was responsible for derepression of cytotoxin expression
and increased virulence of USA500 strains. Although
we did not examine the functional significance of this
arrangement, the role of gene expression regulation is
becoming increasingly recognized to contribute to varia-
tions in virulence and antibiotic resistance of S. aureus
[43,46,54,55] and thus may be of interest to future inves-
tigations into ST772-MRSA-V. Similarly, the functional
role of the agr group II locus in DAR4145 is of interest
as it differs from the agr group III locus found in other
clonal complex 1 strains [56].
Comparison to other STs
There are notable differences between DAR4145 and other
sequenced CA-MRSA strains with regards to acquired anti-
microbial resistance and virulence determinants (Additional
file 1). The level of multi-drug resistance is greater than that
seen in the key CA-MRSA clones from the US – USA300
[57] and MW2 [35], Europe – ST80 [28], Australia – ST93
[58], and Asia – ST59 [59]. In particular, DAR4145has MGEs encoding for resistance to cotrimoxazole and
aminoglycosides that are not present in the other CA-
MRSA genomes. The integrated plasmid harbouring resist-
ance genes blaZ, mphC, aphA-III and msrA is found only
in DAR4145 and ST80 strain 11819–97; although in con-
trast to 11819–97 the integrated plasmid is not within the
SCCmec element in DAR4145 [28].
Although all the above listed CA-MRSA strains harbor
PVL-encoding phage, the combination of sea and PVL
on Φ-IND772PVL only occurs in ST772-MRSA-V [21].
In comparison to the other strains that carry 2–7 entero-
toxin genes, DAR4145 harbors 10 such genes, including
sec and sel on the putative SaPI and the enterotoxin clus-
ter seg, sei, sem, sen and seo on vSaβ. DAR4145 contains
capsid type 5, but lacks both the serine-like protease op-
eron spl and lukD/E. In total, compared to other import-
ant genome sequenced CA-MRSA strains, DAR4145
contains a striking combination of acquired antimicrobial
and virulence determinants. It should be noted that the
small number of available genomes examined in this study
may cause a bias towards isolates that are particularly viru-
lent or multi-drug resistant and therefore may not be an
accurate assessment of these traits in the lineage at large.
However, previous studies on larger collections that in-
cluded molecular typing of resistance and virulence factors
have determined similar resistance profiles and confirmed
the widespread presence of virulence determinants, such
as the egc gene cluster or PVL [7,15,21].Conclusions
The complete genome of ST772-MRSA-V is remarkable
for the presence of multiple MGEs mediating a highly
antibiotic resistant phenotype. This phenotype is further
augmented by the presence of core genome resistance-
associated mutations and redundancy of some resistance
mediating genes. For example, DAR4145 demonstrates
high-level resistance to TMP-SXT (MIC ≥ 320 μg/L) and
contains three relevant resistance genes, dfrA and two cop-
ies of dfrG. Additionally, DAR4145 carries a large comple-
ment of virulence factors including multiple enterotoxins,
α-haemolysin and PVL.
Recommended oral antibiotics for the treatment of
community-associated S. aureus skin and soft tissue
infections include anti-staphylococcal β-lactams, clinda-
mycin, TMP-SXT, erythromycin, and doxycycline [60].
DAR4145 is resistant to all of these antibiotics except
for doxycycline (and even then it carries tet(38), which
if up-regulated could conceivably result in phenotypic
resistance). Unfortunately, a multidrug-resistant geno-
type is not restricted to DAR4145 and appears to be a
consistent feature of all ST772-MRSA-V strains analysed
in this study. Thus, simple oral treatment options for the
ST772 lineage are truly limited.
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and its appearance in multiple regions of the world
[7-9,12-14,20], should raise concerns. As with highly
resistant Gram-negatives, drivers of the emergence and
spread of ST772-MRSA-V need urgent study. Here, we
have defined the bacterial factors that contribute to the
multidrug-resistant phenotype of this lineage. Studies
to understand the global phylogeography of ST772
can now make use of the closed reference genome of
DAR4145.
Methods
Sequencing and assembly
Strain DAR4145 was recovered as a blood culture isolate in
a patient from Mumbai, India in 2009 [31]. This strain was
multilocus sequence type 772, spa type 1080 (Ridom spa
type t657), PVL+, SCCmec V, and dru type 10bk. For this
study, antimicrobial susceptibility testing was performed
with the Vitek2 platform using 22359 VITEK AST-P612
cards (bioMerieux, France) with Clinical and Laboratory
and Standards Institute breakpoints utilised [61].
Sequencing for de novo assembly was performed on
the PacBio RS (Menlo Park, CA, USA). A sequencing
library (SMRTbell) was generated from approximately 2
ug of genomic DNA sheared to an average fragment
length of 10 kb. Library preparation was carried out
following manufacturer protocols using DNA Template
Prep Kit 2.0 (3 – 10 Kb). The sequencing enzyme used
was version 2.0 from the DNA/Polymerase Binding Kit
2.0, movie lengths were 90 min, and sequencing chemis-
try was version C2. From eight SMRT cells of sequen-
cing, we generated 313,192 polymerase reads with
an average length of 3.1 kb (and a total of 401,221
sub-reads with an average length of 2.0 kb, the largest
was 14.7 kb; sub-reads are the individual forward and
reverse reads of every SMRTbell library molecule excised
from a polymerase read). De novo assembly was per-
formed with HGAP v.2.2. Circularisation was achieved
by manual comparison and removal of a region of over-
lap. For short-read re-mapping and error-correction, an
Illumina library with a median insert size of 238 bp (first
and third quartile: 194/303 bp) was generated and se-
quenced on the Illumina HiSeq 2000 with 100 bp
paired-end runs, producing 3,826,612 sequencing reads.
Computational analysis
Automated error correction was performed by mapping
paired-end short reads against the PacBio assembly with
five iterations in iCORN v.2 [62]. Results were con-
firmed with SPANDx v.2.4, using standard parameters
[63]. The corrected reference sequence was annotated
with Prokka v1.07 [64] and supplemented with results
from the annotation servers BASys [65] and RAST [66].
Visual inspection and manual curation was carriedout with Artemis v.16.0.0 [67,68] and BLAST searches
against databases from NCBI [69]. Virulence factors and
phages were identified using VirulenceFinder 1.2 (90%
identity) [70] and the PHAST server [71]. In silico multi-
locus sequence typing (MLST) was performed using the
MLST server v1.3 [72] and validated by mapping paired-
end short reads to a previously assembled MLST data-
base from Sanger Institute.
We obtained publicly available assemblies and short
reads for nine additional whole-genome sequences of
ST772-MRSA-V (07–17048, 118, 120, 333, 3957, 3989,
VH60, LVP2, KT/Y21; see Table 1) for comparison and
visualization with the BLAST Ring Image Generator
(BRIGS) v.0.95 [73]. Each genome was also mapped
against DAR4145 using SMALT v.0.7.5 with default set-
tings, followed by exclusion of regions of known MGEs.
High-quality core genome SNPs were identified using a
combination of SAMtools v.1.1 mpileup and bcftools,
with filters applied as previously described [74]. Genes
and high-quality SNPs implicated with antimicrobial
resistance were identified in all strains by mapping
available short read data against a database of known,
annotated sequences from Sanger Institute with SMALT
v.0.7.5 (Sanger Institute) and by using an in-house pipeline
combining GATK v.3.3.0 [75,76] and SAMtools v.1.1
[77,78]. Resistance genes were verified with ResFinder
v.2.1 [39] at 80% minimum length and 90% identity cut-
offs, using assemblies ordered against the reference
DAR4145 in Mauve v.2.3.1 [79] in order to determine
their location and genomic context. Specific regions of
interest (i.e., resistance genes, phages, virulence factors)
were further investigated and validated by mapping
available short reads of isolates, including DAR4145,
against the PacBio assembly with standard parameters in
SPANDx. Finally, we obtained representative genomes of
five significant STs for comparison with ST772-MRSA-V
in ResFinder and Virulence Finder: MW2 [GenBank:
BA000033.2], USA300 FPR3757 [GenBank: CP000255.1],
ST59 M013 [GenBank: CP0003166.1], ST80 11819–97
[GenBank: CP003194.1] and ST93 JKD6159 [GenBank:
CP002114.2]. Results were visualized as a presence/ab-
sence matrix in MS Excel 2010.
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